{"id":"https://openalex.org/W4396765366","doi":"https://doi.org/10.1016/j.diagmicrobio.2024.116344","title":"In vitro antibacterial activity of sulbactam-durlobactam in combination with other antimicrobial agents against Acinetobacter baumannii-calcoaceticus complex","display_name":"In vitro antibacterial activity of sulbactam-durlobactam in combination with other antimicrobial agents against Acinetobacter baumannii-calcoaceticus complex","publication_year":2024,"publication_date":"2024-05-09","ids":{"openalex":"https://openalex.org/W4396765366","doi":"https://doi.org/10.1016/j.diagmicrobio.2024.116344","pmid":"https://pubmed.ncbi.nlm.nih.gov/38735147"},"language":"en","primary_location":{"id":"doi:10.1016/j.diagmicrobio.2024.116344","doi":"https://doi.org/10.1016/j.diagmicrobio.2024.116344","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.diagmicrobio.2024.116344","pdf_url":null,"source":{"id":"https://openalex.org/S80485324","display_name":"Diagnostic Microbiology and Infectious Disease","issn_l":"0732-8893","issn":["0732-8893","1879-0070"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diagnostic Microbiology and Infectious Disease","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.diagmicrobio.2024.116344","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084120016","display_name":"Sarah M. McLeod","orcid":"https://orcid.org/0009-0003-7827-794X","observed_orcids":["https://orcid.org/0009-0003-7827-794X"]},"institutions":[{"id":"https://openalex.org/I4210159505","display_name":"Entasis Therapeutics (United States)","ror":"https://ror.org/05f9hgh77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159505"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sarah M. McLeod","raw_affiliation_strings":["Entasis Therapeutics Inc., an affiliate of Innoviva Specialty Therapeutics, Inc., Waltham, MA, USA. Electronic address: Sarah.McLeod@istx.com","Entasis Therapeutics Inc., an affiliate of Innoviva Specialty Therapeutics, Inc., Waltham, MA, USA"],"raw_orcid":"https://orcid.org/0009-0003-7827-794X","affiliations":[{"raw_affiliation_string":"Entasis Therapeutics Inc., an affiliate of Innoviva Specialty Therapeutics, Inc., Waltham, MA, USA. Electronic address: Sarah.McLeod@istx.com","institution_ids":["https://openalex.org/I4210159505"]},{"raw_affiliation_string":"Entasis Therapeutics Inc., an affiliate of Innoviva Specialty Therapeutics, Inc., Waltham, MA, USA","institution_ids":["https://openalex.org/I4210159505"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008213744","display_name":"Nicole Carter","orcid":"https://orcid.org/0000-0002-3946-8052","observed_orcids":["https://orcid.org/0000-0002-3946-8052"]},"institutions":[{"id":"https://openalex.org/I4210159505","display_name":"Entasis Therapeutics (United States)","ror":"https://ror.org/05f9hgh77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159505"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicole M. Carter","raw_affiliation_strings":["Entasis Therapeutics Inc., an affiliate of Innoviva Specialty Therapeutics, Inc., Waltham, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Entasis Therapeutics Inc., an affiliate of Innoviva Specialty Therapeutics, Inc., Waltham, MA, USA","institution_ids":["https://openalex.org/I4210159505"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075544791","display_name":"Patricia A. Bradford","orcid":"https://orcid.org/0000-0002-1285-2978","observed_orcids":["https://orcid.org/0000-0002-1285-2978"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patricia A. Bradford","raw_affiliation_strings":["Antimicrobial Development Specialists, LLC, Nyack, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antimicrobial Development Specialists, LLC, Nyack, NY, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006271408","display_name":"Alita A. Miller","orcid":"https://orcid.org/0000-0002-7110-0493","observed_orcids":["https://orcid.org/0000-0002-7110-0493"]},"institutions":[{"id":"https://openalex.org/I4210159505","display_name":"Entasis Therapeutics (United States)","ror":"https://ror.org/05f9hgh77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159505"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alita A. Miller","raw_affiliation_strings":["Entasis Therapeutics Inc., an affiliate of Innoviva Specialty Therapeutics, Inc., Waltham, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Entasis Therapeutics Inc., an affiliate of Innoviva Specialty Therapeutics, Inc., Waltham, MA, USA","institution_ids":["https://openalex.org/I4210159505"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5084120016"],"corresponding_institution_ids":["https://openalex.org/I4210159505"],"apc_list":{"value":3190,"currency":"USD","value_usd":3190},"apc_paid":{"value":3190,"currency":"USD","value_usd":3190},"fwci":1.208,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.73259582,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":97},"biblio":{"volume":"109","issue":"3","first_page":"116344","last_page":"116344"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sulbactam-durlobactam","display_name":"sulbactam-durlobactam","score":0.9649999737739563},{"id":"https://openalex.org/keywords/acinetobacter-baumannii","display_name":"Acinetobacter baumannii","score":0.9760000109672546},{"id":"https://openalex.org/keywords/acinetobacter-calcoaceticus","display_name":"Acinetobacter calcoaceticus","score":0.8840000033378601},{"id":"https://openalex.org/keywords/combination-antibiotic-therapy","display_name":"combination antibiotic therapy","score":0.5419999957084656},{"id":"https://openalex.org/keywords/beta-lactamase-inhibitors","display_name":"beta-lactamase inhibitors","score":0.7739999890327454},{"id":"https://openalex.org/keywords/beta-lactam-antibiotics","display_name":"beta-lactam antibiotics","score":0.7609999775886536},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.492000013589859},{"id":"https://openalex.org/keywords/checkerboard-assay","display_name":"checkerboard assay","score":0.6690000295639038}],"concepts":[{"id":"https://openalex.org/C2778478555","wikidata":"https://www.wikidata.org/wiki/Q423393","display_name":"Sulbactam","level":5,"score":0.9297852516174316},{"id":"https://openalex.org/C2776315533","wikidata":"https://www.wikidata.org/wiki/Q3241189","display_name":"Acinetobacter baumannii","level":4,"score":0.8903912305831909},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.7909472584724426},{"id":"https://openalex.org/C2779168147","wikidata":"https://www.wikidata.org/wiki/Q460711","display_name":"Checkerboard","level":2,"score":0.7120664119720459},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.693767249584198},{"id":"https://openalex.org/C2777383412","wikidata":"https://www.wikidata.org/wiki/Q4770891","display_name":"Antagonism","level":3,"score":0.6554553508758545},{"id":"https://openalex.org/C2775859738","wikidata":"https://www.wikidata.org/wiki/Q4674168","display_name":"Acinetobacter calcoaceticus","level":4,"score":0.5691145062446594},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.48938435316085815},{"id":"https://openalex.org/C2778523567","wikidata":"https://www.wikidata.org/wiki/Q310457","display_name":"Acinetobacter","level":3,"score":0.4433172941207886},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.4148949384689331},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.27246180176734924},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.24956080317497253},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.1790507733821869},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.14281311631202698},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08418309688568115},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.04958680272102356},{"id":"https://openalex.org/C2779631663","wikidata":"https://www.wikidata.org/wiki/Q425152","display_name":"Imipenem","level":4,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000151","descriptor_name":"Acinetobacter Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000151","descriptor_name":"Acinetobacter Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013407","descriptor_name":"Sulbactam","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016954","descriptor_name":"Acinetobacter calcoaceticus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D040981","descriptor_name":"Acinetobacter baumannii","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D053961","descriptor_name":"Azabicyclo Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D065093","descriptor_name":"beta-Lactamase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.diagmicrobio.2024.116344","doi":"https://doi.org/10.1016/j.diagmicrobio.2024.116344","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.diagmicrobio.2024.116344","pdf_url":null,"source":{"id":"https://openalex.org/S80485324","display_name":"Diagnostic Microbiology and Infectious Disease","issn_l":"0732-8893","issn":["0732-8893","1879-0070"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diagnostic Microbiology and Infectious Disease","raw_type":"journal-article"},{"id":"pmid:38735147","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38735147","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diagnostic microbiology and infectious disease","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.diagmicrobio.2024.116344","doi":"https://doi.org/10.1016/j.diagmicrobio.2024.116344","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.diagmicrobio.2024.116344","pdf_url":null,"source":{"id":"https://openalex.org/S80485324","display_name":"Diagnostic Microbiology and Infectious Disease","issn_l":"0732-8893","issn":["0732-8893","1879-0070"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diagnostic Microbiology and Infectious Disease","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320317528","display_name":"Entasis Therapeutics","ror":"https://ror.org/05f9hgh77"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1499823044","https://openalex.org/W1982551127","https://openalex.org/W2042164350","https://openalex.org/W2104582297","https://openalex.org/W2149579827","https://openalex.org/W2515950493","https://openalex.org/W2728041751","https://openalex.org/W2950892680","https://openalex.org/W3014723075","https://openalex.org/W3116081501","https://openalex.org/W3212629960","https://openalex.org/W4241227411","https://openalex.org/W4307585197","https://openalex.org/W4378514987","https://openalex.org/W4387651488"],"related_works":["https://openalex.org/W4416572833","https://openalex.org/W4389572944","https://openalex.org/W4389030568","https://openalex.org/W4392359193","https://openalex.org/W7122673977","https://openalex.org/W4406930943","https://openalex.org/W4383746906","https://openalex.org/W3017239476","https://openalex.org/W4413107307","https://openalex.org/W4367600544"],"abstract_inverted_index":{"Combinations":[0],"of":[1,14,28],"the":[2],"\u03b2-lactam/\u03b2-lactamase":[3],"inhibitor":[4],"sulbactam-durlobactam":[5,33],"and":[6],"seventeen":[7],"antimicrobial":[8,48],"agents":[9],"were":[10],"tested":[11],"against":[12,36],"strains":[13],"Acinetobacter":[15],"baumannii":[16,38],"in":[17,23],"checkerboard":[18],"assays.":[19],"Most":[20],"combinations":[21],"resulted":[22],"indifference":[24],"with":[25,46],"no":[26],"instances":[27],"antagonism.":[29],"These":[30],"results":[31],"suggest":[32],"antibacterial":[34],"activity":[35],"A.":[37],"is":[39],"unlikely":[40],"to":[41],"be":[42],"affected":[43],"if":[44],"co-dosed":[45],"other":[47],"agents.":[49]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2024-05-10T00:00:00"}